Past event: MASS West - Medical Affairs Strategic Summit

Develop a unified scientific voice and ultimtely hekp position your medical affairs group as a strategic, customer-facing function

Medical Affairs Executive Strategy

Medical affairs teams are involved in nearly all aspects of communication in a pharmaceutical/biotechnology/medical device organization. Their scope and authority can vary depending on the size of the business. One of the biggest issues medical affairs teams have faced in recent years has been the need to establish standard operating procedures and quality control measures for social media posts. With Twitter, Facebook and other networks in use by virtually all employees, medical affairs teams need to pinpoint who regulates company posts, what information is released and how posts should be edited.

This track will address the management and communication concerns internal teams face as well as how to best improve current processes in order to comply with new regulations and the instant access to information.

This conference is designed for representatives from pharmaceutical, biotechnology and medical device organizations with responsibilities in the following areas:
  • Medical Affairs/Field Medical Affairs
  • Medical Science/Field Medical Science
  • Clinical/Scientific Affairs
  • Medical Strategy/Communications
  • Key Opinion Leadership/Thought Leadership/Opinion Leader Relationships
  • Research and Development
  • Medical Education
  • Publication Planning
  • Scientific Communication
  • Program Management
  • Quality Assurance
  • Scientific Engagements
  • Medical Science Liaisons


MSL Best Practices

The role of the medical science liaison (MSL) has continued to expand. Previously, MSLs served as the link between their respective organizations and key opinion leaders (KOLs). As subject matter experts, MSLs convey product information to educate the KOL, then relay information back to their own organization. While this has not changed, MSLs are now taking on a more hybrid role, encompassing account/relationship management responsibilities in addition to interacting with clinical and business teams. To maintain the expanding list of responsibilities, MSLs need to be continuously trained and assessed for regulatory compliance and other various roles.

Accompanying the growth of the MSL role, data indicates that KOLs and physicians increasingly prefer to work with MSLs instead of sales or account managers.

The MSL Best Practices track will focus on the MSL's growing duties and on the exchange of MSL training and evaluation techniques in both small and large organizations.

This conference is designed for representatives from pharmaceutical, biotechnology and medical device organizations with responsibilities in the following areas:
  • Medical Science Liaisons
  • Medical Science
  • Medical Strategy
  • Scientific Communication
  • Medical Education
  • Key Opinion Leadership/Thought Leadership/Opinion Leader Relationships


Featuring Presentations, Panel Discussions and Case Studies, Including:

  • DOJ Keynote Address: Enforcement Viewpoints and Priorities for the U.S. Department of Justice
  • Medical Affairs Powering Up for an Effective Product Launch
  • Appreciate the Evolution of the MSL and Pharma/Payer Trends That Offer Optimal Impactful Communication Tactics
  • Panel: How to Set Up Compliance Firewalls That Balance SOPs With Practical Needs
  • Panel: Develop a Streamlined Process for Gathering Clinical and Field Insights and Translate That Data Internally to Shape Medical Strategy
  • Successfully Operationalizing a Franchise-Level Scientific Communication Platform


Who Should Attend:

This conference is designed for representatives from pharmaceutical, biotechnology, and medical device organizations with responsibilities in the following areas:
  • Medical Affairs/Field Medical Affairs
  • Clinical/Scientific Affairs
  • Medical Science Liaisons/MSLs
  • Medical Strategy/Communications
  • Medical/Clinical Operations
  • KOL/Thought Leader Relations/Engagement
  • Investigator-Initiated Research (IIR)
  • Investigator-Initiated Studies (IIS)
  • Investigator-Initiated Trials (IIT)
  • Investigator-Sponsored Trials (IST)
  • Research Collaborations
  • Medical/Scientific/Patient Communications
  • Medical Information
  • Medical Education
  • Publication Planning
  • Health Economics and Outcomes Research/HEOR
  • Compliance/Legal
  • Regulatory Affairs
  • Research Grants
  • Call Center Management
  • Patient Services
  • Clinical Outcomes and Publications

This conference is also designed for:
  • KOL and Thought Leader Mapping Organizations
  • Data Management Vendors
  • Clinical Trial Service Providers
  • Scientific and Technology Solutions Providers
  • Medical Affairs Service Organizations
  • Medical and Scientific Communication Vendors
  • Talent Acquisition Service Providers
  • Call Center Vendors
  • Companion Diagnostics
  • Data Management Solution Providers
  • Clinical Outcomes and Publications

Speakers

  • Heather S. Ambrose, Director, Acute Care Field Medical and Patient Advocacy, BTG INTERNATIONAL
  • Katie Anders, Head of Medical Affairs Strategic Solutions (MASS), MEDSCAPE EDUCATION
  • Kay Baldwin, Associate Regional Director, KERYX BIOPHARMACEUTICALS
  • Julie Baron, Ph.D., Director, Field Medical Effectiveness, SHIRE
  • Lynn Bass, Director, Medical Science Liaisons (Americas), SANTEN
  • Philip Bedrin, Director of Sales, North America, SCIENCEMEDIA, INC.
  • Colville Brown, M.D., Medical Director, EGALET CORPORATION
  • David Bruhn, Pharm.D., MBA, Director, Health Outcomes Liaisons - Government, Medical Policy and Payers, US Medical Affairs, GSK
  • Christine Chatas, Director, Medical Liaisons, ALEXION
  • Cristina Costantino, Ph.D., MBA, Senior Scientific Communications Director, GENENTECH
  • Duke Dickerson, Ph.D., M.Sc., MBA, Regional Medical Director, Orphan and Rare Diseases, HORIZON PHARMA
  • Christian Dimaano, Ph.D., MPH, National Director, Oncology MSLs, Medical Affairs, Americas, ASTELLAS PHARMA
  • Elizabeth Faust, Ph.D., Vice President, Medical Affairs, KITE PHARMA
  • Jayne Gershkowitz, Chief Patient Advocate, AMICUS THERAPEUTICS
  • Tricia L. Gooljarsingh, Senior Director, Medical and Scientific Affairs, IRONWOOD PHARMACEUTICALS
  • Julie Greely, Pharm.D., Senior Director, Field Excellence and HEOR, Medical Affairs, Americas, ASTELLAS PHARMA INC
  • Lance Hill, CEO, WITHIN3
  • Brenna E. Jenny, Counsel, U.S. DEPARTMENT OF JUSTICE
  • Ayman R. Kafal, Ph.D., MBA, Associate Director, Specialty Field Team, Medical Affairs, CSL BEHRING
  • Vaibhav Katkade, M.D., Ph.D., Senior Director, Global TA Medical Lead, XELIANZ
  • Richard Kho, Ph.D., Head of Life Sciences, KOMODO HEALTH
  • Sheila Komara, Ph.Dc., RN, Senior Medical Science Liaison, MALLINCKRODT
  • Mark Lyles, M.D., MBA, Executive Director, Medical Affairs Strategy, AMICUS THERAPEUTICS
  • Susan Malecha, Pharm.D., MBA, Lead, National Managed Care Liaisons, PACE (Patient Access Collaboration and Exchange), U.S. Medical Affairs, GENENTECH
  • Ilene Pedroso, Ph.D., East Regional MSL Director, Critical Care, MALLINCKRODT PHARMACEUTICALS
  • Elizabeth L. Pham, Senior Director, Global Publications, HALOZYME THERAPEUTICS
    Kunal Ramani, Pharm.D., Senior Medical Science Liaison, STRONGBRIDGE BIOPHARMA
  • Paul Rowe, M.D., Vice President, Head of Global Medical Affairs, Immunology - Airway, SANOFI
  • Bruce M. Schechter, Pharm.D., CMPP, Director, Scientific Communications, Rheumatology Therapeutic Area Lead, Medical Scientific Affairs Operations, IRONWOOD PHARMACEUTICALS
  • Scott Siegert, Pharm.D., MBA, Executive Director, Head of Medical Affairs, NEUROCRINE BIOSCIENCES
  • Daniel Snyder, Head, Medical Affairs, REVANCE THERAPEUTICS
  • Jeymi Tambiah, M.D., Senior Vice President, Medical Affairs, SAMUMED LLC
  • Radhika Tripuraneni, M.D., Vice President, Medical Affairs, PROTHENA BIOSCIENCES
  • Michael W. Young, Vice President Strategic Accounts, SCIENCEMEDIA

Please fill in your name and email to receive the conference agenda of this event.


Pre-Conference Workshops - Monday, September 24, 2018

Conference Day One - Tuesday, September 25, 2018

Conference Day Two
- Wednesday, September 26, 2018

Venue

The venue is not yet available for this event.
Follow this event to be informed when the venue is available and stay informed on other changes.

Venue

San Diego Marriott Del Mar
11966 El Camino Real
San Diego, CA 92130

To make reservations over the phone, please call 877-759-6290 and request the negotiated rate for ExL's MASS West.

To make reservations online Click Here

You must book your room by September 4, 2018 in order to receive the group rate. Please book your room early, as rooms available at this rate are limited.

877-759-6290
Event details
Organizer : ExL
Event type : Conference
Reference : ASDE-18860